by TractManager | Oct 26, 2021 | Emerging Technology Report
Susvimo (ranibizumab injection) is a refillable ocular implant containing the vascular endothelial growth factor (VEGF) inhibitor ranibizumab indicated for the treatment of patients with neovascular (wet) age-related macular degeneration (AMD) who have previously...
by TractManager | Oct 25, 2021 | Emerging Technology Report
Balstilimab is an investigational intravenous immunotherapy. It inhibits the activity of programmed death-1 (PD-1), an immune checkpoint protein that helps restrain the immune system. Balstilimab is proposed for the second-line treatment of advanced cervical cancer in...
by TractManager | Oct 22, 2021 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Somryst (Pear Therapeutics Inc.) for the treatment of chronic insomnia in adults.If you have a Hayes login, click...
by TractManager | Oct 20, 2021 | News
The Food and Drug Administration (FDA) recently issued the following safety alerts: Cook Medical Transseptal Needle and Transseptal Needle with CatheterOn October 8, 2021, Cook Medical issued a global, voluntary recall of the transseptal needle and the transseptal...
by TractManager | Oct 20, 2021 | Emerging Technology Report
The Lungpacer Diaphragm Pacing Therapy (DPT) system is a temporary, minimally invasive, transvenous phrenic nerve pacing system intended for treatment of patients on mechanical ventilation to facilitate weaning from the ventilator.
Recent Comments